BioSpace News Archive

Drug Development

Jounce Therapeutics Reports Results from Phase 2 Randomized SELECT Trial Testing 2 Different Doses of Vopratelimab in TISvopra Biomarker-Selected Patients

Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today reported top line data from the randomized Phase 2 SELECT trial evaluating vopratelimab (vopra).

August 30, 2022
·
10 min read
Genetown

Collegium Announces 11 Poster Presentations at PAINWeek 2022 National Conference

Collegium Pharmaceutical, Inc. announced that 11 poster presentations highlighting data regarding its product portfolio will be presented at the Annual PAINWeek National Conference, taking place September 6-9, 2022 in Las Vegas, NV.

August 30, 2022
·
67 min read
GENE Momentum building - a year in review

Genetic Technologies Limited, a global leader in guideline driven genomics-based tests in health, wellness and serious disease is pleased to report annual results for the year ended June 30, 2022.

August 30, 2022
·
8 min read
Deals

Medtronic completes acquisition of Affera

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it has completed the acquisition of Affera, Inc.

August 30, 2022
·
5 min read
InMode to Present at the Baird 2022 Global Healthcare Conference

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer, will present at the Baird 2022 Global Healthcare Conference on Sept. 13, 2022, at the InterContinental New York Barclay hotel.

August 30, 2022
·
1 min read
Genetown

FDA Allows Patient Enrollment to Resume in Monotherapy Dose Escalation of Emavusertib in TakeAim Leukemia Study

Curis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified Curis that it may resume enrollment of additional patients in the monotherapy phase of the TakeAim Leukemia study.

August 30, 2022
·
11 min read
Pharm Country

INOVIO to Present at the H.C. Wainwright 24th Annual Global Investment Conference

INOVIO today announced that Jacqueline Shea , Ph.D., President and CEO, will present at the H.C. Wainwright 24th Annual Global Conference.

August 30, 2022
·
1 min read
Business

DiamiR Biosciences Expands Management Team with the Appointment of Fred Knechtel as its Chief Financial Officer

DiamiR today announced the expansion of its management team by the appointment of Fred Knechtel as Chief Financial Officer (CFO), effective immediately.

August 30, 2022
·
2 min read
Biotech Bay

S2 Genomics signs Eisenberg for Israel Distribution for the Singulator™ 100 System to Accelerate Single-Cell Genomics Research

S2 Genomics, Inc., today announced that it has entered into a distribution agreement with Eisenberg for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in Israel.

August 30, 2022
·
2 min read
BioForest

Parse Biosciences Releases Whole Transcriptome Version 2 Chemistry with Marked Performance Enhancements

Parse Biosciences announced today a significant performance update of its chemistry for the Evercode™ Whole Transcriptome products.

August 30, 2022
·
2 min read